Coronavirus Disease 2019 (COVID-19) has transmitted almost all over the world. COVID-19 is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which transfers from an infected person to a susceptible person via direct contact (e.g., hand-shaking, hugging) or indirect contact through touching materials or objects that are contaminated by an infected person (e.g., doorknob, handrail, paper tissue). It can also spread via airborne route (i.e. through aerosols created by expiratory activities). After entering the respiratory tract of human body, SARS-CoV-2 bioparticles may cause the most common symptoms of fever, cough, and fatigue. They may also cause sore throat, headache, chill, runny nose, loss of taste or smell, skin rash, muscle pain, nausea and vomiting, loss of appetite, diarrhea, dizziness, abdominal pain, and discoloration of fingers or toes. The severe symptoms of COVID-19 are shortness of breath or difficulty in breathing, chest pain, and loss of speech or movement. Recently, blood clotting has emerged as a new risk of COVID-19. Indeed, skin rash and discoloration of fingers or toes are the visible signs of blood clotting. The reduction of oxygen level in blood is another indication of blood clotting, as the oxygen supply to the tissues and organs of human body will be greatly affected if blood clots occur. The following are the probable causes of blood clotting.
1. SARS-CoV-2 particles can increase the viscosity of blood because of their own physical characteristics. The outer surface of SARS-CoV-2 having protein spikes may cause friction with other ingredients of blood (e.g., red cells, white cells, and platelets) and among themselves. They can also cause friction on the surface of the innermost layer (tunica intima) of blood vessels. It means the blood flow in the blood vessels will be hindered due to the increased resistance against flow. Such impaired blood flow may contribute to cause blood clotting.
2. SARS-CoV-2 particles may increase the viscosity of blood by increasing the concentration of the bioparticles in blood. The viscosity of whole blood is directly related to the viscosity of its plasma (the higher the viscosity of plasma, the greater will be the viscosity of whole blood) and the concentration (volume fraction) of the bioparticles present in blood (the larger the concentration of the bioparticles, the greater will be the viscosity of whole blood). This means the effective viscosity of whole blood will increase with the increasing volume fraction of the bioparticles existing in blood. It implies that the whole blood shall be thicker when the increased load of virus particles increases the volume concentration of the bioparticles in blood. The extremely increased viscosity could lead to blood clotting in human body.
3. SARS-CoV-2 particles could interlock with each other because of their characteristic outer layer having protein spikes, leading to formation of virus cluster. This physical process may also involve other blood particles (e.g., blood cells). In addition, the stickiness of the envelope of SARS-CoV-2 due to its spike protein (S-protein) and envelope protein (E-protein) could help forming the clusters of virus particles and blood cells. It implies that SARS-CoV-2 may collectively form obstacles across the blood flow direction, thus contributing to blood clotting.
4. SARS-CoV-2 particles may attach to the inner lining (tunica intima) of blood vessels, taking the benefit of their sticky outer layer, thus narrowing the vessel space along the direction of the blood flow (i.e., the cross-sectional area of blood vessels across the blood flow direction decreases). It is also possible that SARS-CoV-2 particles assemble in several layers with the foremost layer attaching to the tunica intima of blood vessels. Such array of virus particles will also decrease the cross-sectional area of the blood vessel across the blood flow direction. Consequently, the blood flow will be significantly obstructed. Furthermore, the endothelial cells of tunica intima may not help regulate the pressure for blood flow when they are lined with SARS-CoV-2 particles. The production of enzymes (e.g., nitric oxide) that help inhibit blood clotting may also be impeded when the endothelial cells are attacked by SARS-CoV-2 particles. These probable consequences eventually may cause blood clotting in extreme condition.
5. The physical structure of tunica intima reveals that SARS-CoV-2 particles could easily be attached to the endothelial cell-to-cell links. These links are very thin compared to the other parts of tunica intima. Hence, the inner lining can easily be ruptured by SARS-CoV-2 particles at those thin links and the underlying internal elastic membrane can be exposed. This damage may trigger blood clotting inside the blood vessels. The breaching of tunica intima shall result in rushing of additional platelets and clotting factors (e.g., prothrombin, fibrinogen) to the damage sites and they will start the process for the formation of blood clots.
6. SARS-CoV-2-induced cytokine storm may be another reason of blood clotting in the blood vessels. Coronaviruses can reach different locations of human body including the blood vessels although they first penetrate the lungs. When the endothelial cells in tunica intima are injured by SARS-CoV-2, they send “SOS” to the immune cells, which rush to the damage sites. The immune cells crowd on the damage sites. The activated immune cells secrete small proteins called cytokines, which prevent the pathogens (e.g., bacteria, viruses) from spreading in the body, contributing to blood coagulation (thickening) with increased viscosity. However, excessive cytokines may lead to uncontrollable blood coagulation. In such condition, anti-coagulants (thinner) present in the whole blood are not quite enough to inhibit blood clotting.
7. SARS-CoV-2 particles would decrease the velocity of whole blood being in the blood vessel. This is due to the additional mass of viruses or owing to the thickening of blood in the presence of virus particles. Since blood is a non-Newtonian flow, its viscosity increases at a lower velocity. Also, the low flow state of blood enhances the molecular interactions of blood cells among themselves and with plasma proteins. Consequently, blood cells (particularly red cells) can agglomerate to form clusters of cells, and thus further increase the viscosity of blood. At a very high viscosity caused by high degree of molecular interactions, blood may stop flowing if the driving pressure remains below the yield stress that initiate flow. Moreover, platelets can get closer at a higher viscosity and the cluster of platelets, acting along with plasma proteins, can entrap red cells to form blood clotting.
